Julio Pimentel

Also affiliated with The Barbara Ann Karmanos Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance”.

Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance

Frontiers in Oncology(2022)10.3389/fonc.2022.908603

N/A

0.432DataRank · unranked

7 citations

Junying Zhou, Julio Pimentel, Steve M. Patrick, Seongho Kim, Malathy P.V. Shekhar +2 more

Targeting PP2A inhibits the growth of triple-negative breast cancer cells

Cell Cycle(2020)10.1080/15384101.2020.1723195

N/A

0DataRank · unranked

19 citations

Julio Pimentel, Madhumita Chatterjee, Joshu E. Allen, Zhengping Zhuang, Gen Sheng Wu +1 more

Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells

Molecular Carcinogenesis(2022)10.1002/mc.23471

N/A

0DataRank · unranked

15 citations

Junying Zhou, Gen Sheng Wu, Julio Pimentel

The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer

Cancers(2023)10.3390/cancers15102752

N/A

0DataRank · unranked

107 citations

Junying Zhou, Gen Sheng Wu, Julio Pimentel

Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78

Current Issues in Molecular Biology(2025)10.3390/cimb47100829

N/A

0DataRank · unranked

1 citations

Julio Pimentel, Junying Zhou, Thamarahansi Mugunamalwaththa, Zhe Yang, Avraham Raz +2 more